First name,Last name,Preferred title,Overview,Position,Department,Individual
Shannon,Glaser,Professor,"The long-term goal of my research program is to understand how activated (proliferating) cholangiocytes participate in the progression of cholestatic liver diseases and eventual development of cholangiocarcinoma. My research is focused on elucidating the factors (such as, mechanical stress) and intracellular signaling mechanisms that regulate cholangiocyte proliferation and biliary fibrosis during extrahepatic cholestasis.",Professor,Medical Physiology,https://scholars.library.tamu.edu/vivo/display/n424a02f1
Travis,Hein,Professor,"My laboratory studies the regulation of microvascular function at the level of arterioles in the retinal and coronary circulations. Sufficient blood flow supply of oxygen and nutrients to tissues to maintain normal function is controlled in large part by changes in the diameter of arterioles. Vasoconstriction or vasodilation of these small arteries will decrease or increase blood flow and nutrient delivery to the tissue, respectively. Two key chemical factors that are produced within the endothelial cells of blood vessels to control their diameter are nitric oxide (NO), a vasodilator, and endothelin-1, a vasoconstrictor. An imbalance in the production and/or release of these vasoactive factors has been implicated in the early stages of several cardiovascular diseases, but the underlying mechanisms contributing to these pathophysiological changes remain unclear. To address this knowledge gap, our research focuses on identifying cellular and molecular mechanisms that contribute to the vasomotor responses of arterioles to NO and endothelin-1 under conditions of health and disease. Current approaches that we use to investigate these mechanisms in the microcirculation include isolated and perfused arterioles, cultured vascular endothelial and smooth muscle cells, biochemical and molecular techniques (for detection of NO, superoxide anion, protein, and mRNA in arterioles), pharmacological and silencing RNA (siRNA) treatments, and blood flow velocity assessment via Doppler ultrasound.",Professor,Medical Physiology,https://scholars.library.tamu.edu/vivo/display/n45051e1b
Cynthia,Meininger,Professor,"My research focuses primarily on the vascular complications of diabetes. Using animal models of human diabetes, we have demonstrated that an inability of endothelial cells to produce nitric oxide may be partly responsible for these vascular complications. We are developing a gene/drug therapy approach for treating cardiovascular disease associated with diabetes. Targeted nanoparticles will deliver either the gene for GTPCH or BH4 itself into endothelial cells oxidatively damaged by diabetes to correct endothelial GTPCH deficiency, increase tetrahydrobiopterin levels, restore nitric oxide production and reverse the vascular dysfunction seen in diabetes. Our endothelium-targeting nanoparticle approach will not only reverse the damage caused by disease but will increase antioxidant levels to protect the endothelial cells from future damage and/or dysfunction.",Professor,Medical Physiology,https://scholars.library.tamu.edu/vivo/display/n531a623d
Paula,Shireman,Professor,"Dr. Shireman is a Professor in the TAMU School of Medicine. She is board certified in vascular surgery, general surgery, wound care and clinical informatics. She is the PI of a pilot clinical trial with the College of Engineering on establishing artificial intelligence algorithms to monitor activities of daily living (ADL) in elderly subjects. Potential applications include aging in place, improved monitoring in healthcare/assisted living institutions and remote monitoring.
She is the PI of an NIH multicenter U01 grant developing predictive models for surgical outcomes including frailty and social risk factors. The goal is to use data to transform health care, influence federal policy and design financially sustainable care pathways improving outcomes for frail and low socioeconomic status patients. Her interests include predictive modeling, machine learning and simulation. She was a member of the MACRA Episode-Based Cost Measure Clinical Subcommittee to develop measures for Peripheral Vascular Disease Management and Chair of the Clinical Subcommittee Workgroup for Hemodialysis Access Creation.","Professor||Professor, Primary Care & Rural Medicine",Medical Physiology||School of Medicine,https://scholars.library.tamu.edu/vivo/display/n7fcb580a
Brett,Mitchell,Professor,Our research focuses on understanding the mechanisms by which immune system activation causes organ dysfunction and various forms of hypertension.,Professor,Medical Physiology,https://scholars.library.tamu.edu/vivo/display/ne0d93385